FDMT icon

4D Molecular Therapeutics
FDMT

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$30
180% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
RBC Capital
RBC Capital
Lisa Walter
50% 1-yr FDMT win rate
11 Nov ‘25 29 days ago
Barclays
Barclays
Gena Wang
100% 1-yr FDMT win rate
11 Nov ‘25 29 days ago
Chardan Capital
Chardan Capital
Geulah Livshits
71% 1-yr FDMT win rate
11 Nov ‘25 1 month ago